Filing Details
- Accession Number:
- 0000899243-20-017444
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-22 19:36:57
- Reporting Period:
- 2020-06-18
- Accepted Time:
- 2020-06-22 19:36:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620152 | B Robert Bazemore | C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2020-06-18 | 10,000 | $8.98 | 264,371 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.0001 | Disposition | 2020-06-18 | 10,000 | $22.00 | 254,371 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.0001 | Disposition | 2020-06-18 | 10,000 | $22.00 | 244,371 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-18 | 10,000 | $0.00 | 10,000 | $8.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 323,333 | 2026-02-07 | No | 4 | M | Direct |
Footnotes
- The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the sale of shares acquired by the Reporting Person upon the exercise of options described in Table II to this Form 4.
- Represents the sale of shares held by the Reporting Person.
- This option is fully vested.
Billionaire Hedge Funds
